StonvexLoading…
StonvexStonvexStonvexCore line items from IPST's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.71M | $10.12M | $5.40M | $2.41M |
Operating Income | $-66.39M | $-133.94M | $-10.25M | $-9.10M |
Net Income | $-66.74M | $-137.72M | $185.94M | $-10.33M |
EPS (Diluted) | $-134.70 | $-16.03 | $43.58 | $-1.16 |
Total Assets | $42.77M | $108.76M | $482.78M | $26.54M |
Total Liabilities | $10.36M | $10.54M | $62.35M | $29.42M |
Cash & Equivalents | $92.70K | $453.16K | $1.67M | $185.95K |
Free Cash Flow OCF − CapEx | $-2.45M | $-15.40M | $-7.90M | $-3.57M |
Shares Outstanding | 514.17K | 482.55K | 9.15M | 12.73M |